Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
DNA replication in progenitor cells and epithelial regeneration after lung injury requires the oncoprotein MDM2
Shilpa Singh, Catherine A. Vaughan, Christopher Rabender, Ross Mikkelsen, Sumitra Deb, Swati Palit Deb
Shilpa Singh, Catherine A. Vaughan, Christopher Rabender, Ross Mikkelsen, Sumitra Deb, Swati Palit Deb
View: Text | PDF
Research Article Cell biology

DNA replication in progenitor cells and epithelial regeneration after lung injury requires the oncoprotein MDM2

  • Text
  • PDF
Abstract

Depletion of epithelial cells after lung injury prompts proliferation and epithelial mesenchymal transition (EMT) of progenitor cells, and this repopulates the lost epithelial layer. To investigate the cell proliferative function of human oncoprotein MDM2, we generated mouse models targeting human MDM2 expression in either lung Club or alveolar cells after doxycycline treatment. We report that MDM2 expression in lung Club or alveolar cells activates DNA replication specifically in lung progenitor cells only after chemical- or radiation-induced lung injury, irrespective of their p53 status. Activation of DNA replication by MDM2 triggered by injury leads to proliferation of lung progenitor cells and restoration of the lost epithelial layers. Mouse lung with no Mdm2 allele loses its ability to replicate DNA, whereas loss of 1 Mdm2 allele compromises this function, demonstrating the requirement of endogenous MDM2. We show that the p53-independent ability of MDM2 to activate Akt signaling is essential for initiating DNA replication in lung progenitor cells. Furthermore, MDM2 activates the Notch signaling pathway and expression of EMT markers, indicative of epithelial regeneration. This is the first report to our knowledge demonstrating a direct p53-independent participation of MDM2 in progenitor cell proliferation and epithelial repair after lung injury, distinct from a p53-degrading antiapoptotic effect preventing injury.

Authors

Shilpa Singh, Catherine A. Vaughan, Christopher Rabender, Ross Mikkelsen, Sumitra Deb, Swati Palit Deb

×

Figure 1

Generation of transgenic mice expressing human MDM2 in CCSP-expressing lung cells in response to Doxycycline (Dox).

Options: View larger image (or click on image) Download as PowerPoint
Generation of transgenic mice expressing human MDM2 in CCSP-expressing l...
(A) pTREtightMDM2 construct designed to express MDM2 from a TRE-controlled CMV promoter. (B) MDM2 transcript levels normalized by GAPDH expression, representative data from 1 set of mice shown as mean ± SD, and (C) MDM2 protein (immunoblot) expression in lung tissue from tightMDM2 (pTREtightMDM2:CCSPrtTA) or control rtTA (CCSPrtTA) transgenic mice after Dox or sucrose (–Dox) treatment. (D) MDM2 expression in cultured lung cells from tightMDM2 mice after 0, 24, or 48 hours of Dox treatment. Fold induction of MDM2 expression by Dox treatment in C and D were determined by densitometry and are shown at the bottom of the immunoblots. MDM2 transcript levels were determined by qPCR. MDM2 protein expression was determined by immunoblot analysis using an antibody against human MDM2. Erk2 was used as loading control. (E) Representative images (magnification, 20×) showing immunostained lung tissue sections from +Dox or –Dox tightMDM2 mice and +Dox rtTA mice using an antibody against human MDM2. MDM2 protein expression (brown) can be detected around the respiratory bronchiole (RB) after Dox treatment. All experiments were repeated in at least 3 mice.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts